Regeneron Pharmaceuticals Inc (REGN)

Quick ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash	US$ in thousands	2,488,200	2,730,000	3,105,900	2,885,600	2,193,700
Short-term investments	US$ in thousands	6,524,300	8,114,800	4,636,400	2,809,100	1,393,300
Receivables	US$ in thousands	6,211,900	5,667,300	5,328,700	6,036,500	3,111,500
Total current liabilities	US$ in thousands	3,944,300	3,423,400	3,141,300	3,932,500	2,697,400
Quick ratio		3.86	4.82	4.16	2.98	2.48

December 31, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($2,488,200K + $6,524,300K + $6,211,900K) ÷ $3,944,300K
= 3.86

The quick ratio of Regeneron Pharmaceuticals Inc has shown a consistent upward trend over the past five years, starting at 2.48 in December 31, 2020, and reaching 3.86 in December 31, 2024. This indicates that the company's ability to meet its short-term obligations with its most liquid assets has improved steadily over the period. The quick ratio surpassed 2.0 in all years, indicating a healthy liquidity position. However, there was a notable spike in the quick ratio in December 31, 2023, reaching 4.82, which suggests a significant increase in the company's ability to cover its immediate liabilities with its liquid assets. Overall, the increasing trend in the quick ratio reflects positively on Regeneron Pharmaceuticals Inc's liquidity position and ability to address its short-term financial commitments effectively.